About the Authors
- Martin Bergbauer
-
Affiliation Department of Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany
- Markus Kalla
-
Affiliation Department of Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany
- Anne Schmeinck
-
Affiliation Department of Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany
- Christine Göbel
-
Affiliation Department of Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany
- Ulrich Rothbauer
-
Affiliation Biocenter at the Department of Biology II, Ludwig-Maximilians University Munich, Martinsried, Germany
- Sebastian Eck
-
Affiliation Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
- Anna Benet-Pagès
-
Affiliation Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
- Tim M. Strom
-
Affiliation Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
- Wolfgang Hammerschmidt
-
* E-mail: hammerschmidt@helmholtz-muenchen.de
Affiliation Department of Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany
Competing Interests
U.R. is one of the founders and shareholders of ChromoTek, which is developing GFP-specific nanobodies for in vitro and in vivo applications used in this manuscript.
Author Contributions
Conceived and designed the experiments: MB MK WH. Performed the experiments: MB MK AS CG ABP. Analyzed the data: MB AS SE TMS WH. Contributed reagents/materials/analysis tools: UR SE. Wrote the paper: WH.